Insider · CIK 0001202098
Stelios Papadopoulos
Files at EXEL (EXELIXIS, INC.), RGLS (Regulus Therapeutics Inc.). First filing May 16, 2025, latest May 16, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EXEL: EXELIXIS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | EXELIXIS, INC. | $1.6M 36,508 shares | -3% | +82% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | UTender of shares Common Stock | -976,253 | - | - | 64,635 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Common Stock | -64,635 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -60,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Common Stock Purchase Warrant (Right to Buy)derivative | -59,514 | - | - | 0 | Jun 27, 2025 |
| May 29, 2025 | EXEL EXELIXIS, INC. | AGrant or award Common Stock | +9,812 | $0.00 | $0 | 1,289,228 | May 30, 2025 |
| May 15, 2025 | EXEL EXELIXIS, INC. | MOption exercise Common Stock | +20,634 | $19.77 | $408k | 1,300,050 | May 16, 2025 |
| May 15, 2025 | EXEL EXELIXIS, INC. | SOpen-market sale Common Stock | -20,634 | $44.35 | $915k | 1,279,416 | May 16, 2025 |
| May 15, 2025 | EXEL EXELIXIS, INC. | MOption exercise Common Stock | +15,874 | $20.50 | $325k | 1,295,290 | May 16, 2025 |
| May 15, 2025 | EXEL EXELIXIS, INC. | SOpen-market sale Common Stock | -15,874 | $44.35 | $704k | 1,279,416 | May 16, 2025 |
| May 15, 2025 | EXEL EXELIXIS, INC. | MOption exercise Option (right to buy)derivative | -20,634 | $0.00 | $0 | 0 | May 16, 2025 |
| May 15, 2025 | EXEL EXELIXIS, INC. | MOption exercise Option (right to buy)derivative | -15,874 | $0.00 | $0 | 0 | May 16, 2025 |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 1,040,888 | Apr 30, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.